B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.
Shakeel ModakPat ZanzonicoMilan GrkovskiEmily K SlotkinJorge A CarrasquilloSerge K LyashchenkoJason S LewisIrene Y CheungTodd E HeatonMichael P LaQuagliaNai Kong V CheungNeeta Pandit-TaskarPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)
IP RIT 131I-omburtamab was well tolerated with minimal toxicities. Radiation exposure to normal organs was low, making combination therapy with other anticancer therapies feasible.